This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Council of Scientific and Industrial Research. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sunny Goon: Innovator in Non-Alcoholic Fatty Liver Disease Treatment
Introduction
Sunny Goon is a notable inventor based in Kolkata, India. She has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). Her innovative work has led to the development of compounds that target specific enzymes to produce beneficial physiological responses.
Latest Patents
Sunny Goon holds a patent for "Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof." This patent includes compounds that inhibit or modulate the Ubiquitin Ligase COP1 enzyme, which is crucial for treating NAFLD. The compounds are designed to increase the level of adipose triglyceride lipase (ATGL), thereby providing a therapeutic approach to managing this condition.
Career Highlights
Sunny Goon is affiliated with the Council of Scientific and Industrial Research, where she has been involved in groundbreaking research. Her work has not only advanced scientific understanding but also opened new avenues for treatment options in liver diseases.
Collaborations
Sunny has collaborated with esteemed colleagues such as Arindam Talukdar and Partha Chakrabarti. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Sunny Goon's contributions to the treatment of non-alcoholic fatty liver disease exemplify the impact of innovative research in medicine. Her work continues to inspire advancements in the field and offers hope for effective treatments.